Joseph Frank Merola, M.D.
Co-Author
This page shows the publications co-authored by Joseph Merola and Gabriela Cobos.
Connection Strength
0.294
-
OnabotulinumtoxinA for Systemic Sclerosis-associated Raynaud's Phenomenon: A Multi-Institutional Study on Accessibility and Effectiveness. J Drugs Dermatol. 2021 Nov 01; 20(11):1257-1259.
Score: 0.060
-
Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from 2 academic medical centers. J Am Acad Dermatol. 2022 02; 86(2):423-425.
Score: 0.059
-
Lack of association between tumor necrosis factor-a inhibitor use and exacerbation of lupus erythematosus: A retrospective cohort study. J Am Acad Dermatol. 2021 Apr 30.
Score: 0.058
-
Characteristics and treatment of silicone granulomas: A retrospective multicenter cohort of 21 patients. JAAD Int. 2021 Jun; 3:111-114.
Score: 0.058
-
The catch-22 of limited Food and Drug Administration approval for connective tissue disease therapies. J Am Acad Dermatol. 2021 Aug; 85(2):517-519.
Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.